Home › Compare › NVTA vs JEPQ

NVTA vs JEPQ: Dividend Comparison 2026

NVTA yields 10526.32% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVTA wins by $91421458538285344.00M in total portfolio value
10 years
NVTA
NVTA
● Live price
10526.32%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$91421458538285344.00M
Annual income
$89,744,322,218,307,970,000,000.00
Full NVTA calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — NVTA vs JEPQ

📍 NVTA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVTAJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVTA + JEPQ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NVTA pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVTA
Annual income on $10K today (after 15% tax)
$894,736.84/yr
After 10yr DRIP, annual income (after tax)
$76,282,673,885,561,770,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, NVTA beats the other by $76,282,673,885,561,770,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVTA + JEPQ for your $10,000?

NVTA: 50%JEPQ: 50%
100% JEPQ50/50100% NVTA
Portfolio after 10yr
$45710729269142672.00M
Annual income
$44,872,161,109,153,986,000,000.00/yr
Blended yield
98.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JEPQ right now

NVTA
Analyst Ratings
4
Buy
6
Hold
5
Sell
Consensus: Hold
Price Target
$9.75
+51215.8% upside vs current
Range: $2.25 — $17.00
Altman Z
-23.1
Piotroski
4/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVTA buys
0
JEPQ buys
0
No recent congressional trades found for NVTA or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVTAJEPQ
Forward yield10526.32% ✓11.10%
Annual dividend / share$2.00$6.16 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$91421458538285344.00M ✓$44.8K
Annual income after 10y$89,744,322,218,307,970,000,000.00 ✓$2,152.59
Total dividends collected$91309952364754128.00M ✓$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: NVTA vs JEPQ ($10,000, DRIP)

YearNVTA PortfolioNVTA Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$1,063,332$1,052,631.58$11,930$1,110.39+$1.05M → NVTA
2$105,744,905$104,607,140.08$14,133$1,224.34+$105.73M → NVTA
3$9,835,430,757$9,722,283,708.79$16,632$1,340.46+$9835.41M → NVTA
4$855,644,041,989$845,120,131,078.84$19,454$1,457.97+$855644.02M → NVTA
5$69,627,827,846,009$68,712,288,721,080.95$22,626$1,576.08+$69627827.82M → NVTA
6$5,300,152,192,813,391$5,225,650,417,018,161.00$26,175$1,694.09+$5300152192.79M → NVTA
7$377,430,657,448,967,200$371,759,494,602,656,830.00$30,133$1,811.32+$377430657448.94M → NVTA
8$25,145,413,383,015,215,000$24,741,562,579,544,820,000.00$34,531$1,927.17+$25145413383015.18M → NVTA
9$1,567,417,121,474,185,500,000$1,540,511,529,154,359,300,000.00$39,403$2,041.08+$1567417121474185.50M → NVTA
10$91,421,458,538,285,340,000,000$89,744,322,218,307,970,000,000.00$44,787$2,152.59+$91421458538285344.00M → NVTA

NVTA vs JEPQ: Complete Analysis 2026

NVTA — Stock

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Full NVTA Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this NVTA vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVTA vs SCHDNVTA vs JEPINVTA vs ONVTA vs KONVTA vs MAINNVTA vs XYLDNVTA vs QYLDNVTA vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.